Financial highlights on an underlying basis:
- New contract sales achieved a total value of £1.4 billion (annual value £0.7 billion) with contract retention rates maintained at approximately 90%. Sales pipeline replenished to stand at £6 billion annual contract value
- Revenue from continuing operations of £3,285 million, up 2.8%; up 4.2% excluding completion of three large contracts in Q1 2014
- Emerging markets revenues up 5.7% to £1,183 million; up 8.7% excluding the Manus Island contract; with strong underlying growth in Asia Middle East and Latin America
- North America up 5.4%; UK down 3.2%; Europe up 2%
- PBITAaincreased by 4.9% to £193 million (2014: £184 million)
- Emerging markets maintained at £87 million
- Developed markets up 3.2% to £129 million
- Corporate costs of £23 million, down £5 million
- Specific items included net £17 million charge from review and re-measurement of assets, liabilities and legacy contracts. Restructuring charges for the period were £16 million
- Cash from operating businesses was £195 million (2014: £185 million), up 5%.
- Underlying earningsa of £95 million (2014: £86 million), up 10.5%
- Interim dividend up 5% to 3.59p per share
- Net debt at June 2015 was £1,677 million (2014: £1,680 million)
